# FDA Inspection 1172560 - Danipharm A/S - October 01, 2020

Source: https://www.keypedia.com/records/fda_inspections/danipharm-as/fdaa88bd-5f87-4103-b049-945124fb2bc7
Source feed: FDA_Inspections

> FDA Inspection 1172560 for Danipharm A/S on October 01, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172560
- Company Name: Danipharm A/S
- Inspection Date: 2020-10-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 917909 - 2015-03-04](https://www.keypedia.com/records/fda_inspections/danipharm-as/ee6a58a5-a35b-4151-a1e3-82a6cdff47b3)
- [FDA Inspection 740637 - 2011-07-08](https://www.keypedia.com/records/fda_inspections/danipharm-as/8da3f905-1bc9-4d53-abea-8bed525f657c)

Company: https://www.keypedia.com/companies/danipharm-as/f412f586-3132-4bfa-abc7-cda6c0f34c30

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c